Lohp, 5-Fu/Lv and Bevacizumab, Alternative With Cpt-11, 5-Fu/Lv and Cetuximab In Metastatic Crc

Clinical trial NCT00755118 · TERMINATED

Trial details

NCT number: NCT00755118
Sponsor: University Hospital of Crete
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Colorectal Cancer

Start date: 2008-10-01
Primary completion: 2012-08-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.